BRISTAMYCIN Drug Patent Profile
✉ Email this page to a colleague
When do Bristamycin patents expire, and when can generic versions of Bristamycin launch?
Bristamycin is a drug marketed by Bristol and is included in two NDAs.
The generic ingredient in BRISTAMYCIN is erythromycin stearate. There are one hundred and three drug master file entries for this compound. One supplier is listed for this compound. Additional details are available on the erythromycin stearate profile page.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for BRISTAMYCIN?
- What are the global sales for BRISTAMYCIN?
- What is Average Wholesale Price for BRISTAMYCIN?
Summary for BRISTAMYCIN
US Patents: | 0 |
Applicants: | 1 |
NDAs: | 2 |
Raw Ingredient (Bulk) Api Vendors: | 26 |
Patent Applications: | 1 |
Formulation / Manufacturing: | see details |
DailyMed Link: | BRISTAMYCIN at DailyMed |
![BRISTAMYCIN drug patent expirations Drug patent expirations by year for BRISTAMYCIN](/p/graph/s/t/BRISTAMYCIN-patent-expirations.png)
US Patents and Regulatory Information for BRISTAMYCIN
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Bristol | BRISTAMYCIN | erythromycin stearate | TABLET;ORAL | 061304-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
Bristol | BRISTAMYCIN | erythromycin stearate | TABLET;ORAL | 061887-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |